A short note on Sendhil Mullainathan’s contributions to development economics von Ananth, Bindu

Volltext

Evolution of community health workers: the fourth stage von Mor, Nachiket, Ananth, Bindu, Ambalam, Viraj, Edassery, Aquinas, Meher, Ajay, Tiwari, Pearl, Sonawane, Vinayak, Mahajani, Anagha, Mathur, Krisha, Parekh, Amishi, Dharmaraju, Raghu

Volltext

Inclusive Financial Systems: Some Design Principles and a Case Study von Nachiket Mor, Bindu Ananth

Volltext

Liberalisation and Universal Access to Basic Services: Telecommunications, Water and Sanitation, Financial Services, and Electricity von Publishing, OECD

Volltext

How to Provide Healthcare von Tiruvarur, Karthik, Grewal, Swati, Mor, Nachiket, Ananth, Bindu

Volltext

Structured Finance Approaches to Livelihood Projects in India von Ananth, Bindu, Sahasranaman, Anand

Volltext

Regulatory Aspects of Universal Access to Financial Services in India von Ananth, Bindu, Mor, Nachiket

Volltext

Access to Finance and Markets as a Strategy to Address Poverty von Mor, Nachiket, Ananth, Bindu

Volltext

Phase 1-2 Study of Stereotactic Ablative Radiotherapy Including Regional Lymph Node Irradiation in Patients With High-Risk Prostate Cancer (SATURN): Early Toxicity and Quality of L... von Musunuru, Hima Bindu, D'Alimonte, Laura, Davidson, Melanie, Ho, Ling, Cheung, Patrick, Vesprini, Daniel, Liu, Stanley, Chu, William, Chung, Hans, Ravi, Ananth, Deabreu, Andrea, Zhang, Liying, Commisso, Kristina, Loblaw, Andrew

Volltext

SABR in High-Risk Prostate Cancer: Outcomes From 2 Prospective Clinical Trials With and Without Elective Nodal Irradiation von Alayed, Yasir, Cheung, Patrick, Vesprini, Danny, Liu, Stanley, Chu, William, Chung, Hans, Musunuru, Hima Bindu, Davidson, Melanie, Ravi, Ananth, Ho, Ling, Deabreu, Andrea, D'Alimonte, Laura, Bhounr, Zeeba, Zhang, Liying, Commisso, Kristina, Loblaw, Andrew

Volltext

Predictive Parameters of Symptomatic Hematochezia Following 5-Fraction Gantry-Based SABR in Prostate Cancer von Musunuru, Hima Bindu, MD, FRCR(UK), Davidson, Melanie, PhD, Cheung, Patrick, MD, FRCPC, Vesprini, Danny, MSc, MD, FRCPC, Liu, Stanley, MD, PhD, FRCPC, Chung, Hans, MD, FRCPC, Chu, William, MD, FRCPC, Mamedov, Alexandre, PhD, Ravi, Ananth, PhD, D'Alimonte, Laura, BSc, MHSc, Commisso, Kristina, BSc, Helou, Joelle, MD, Deabreu, Andrea, BSc, Zhang, Liying, PhD, Loblaw, Andrew, MD, MSc, FRCPC

Volltext

Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, toxicity and quality of life von Musunuru, Hima Bindu, Cheung, Patrick, Vesprini, Danny, Liu, Stanley K., Chu, William, Chung, Hans T., Morton, Gerard, Deabreu, Andrea, Davidson, Melanie, Ravi, Ananth, Helou, Joelle, Ho, Ling, Zhang, Liying, Loblaw, Andrew

Volltext

Elective nodal ultra hypofractionated radiation for prostate cancer: Safety and efficacy from four prospective clinical trials von Glicksman, Rachel M., Liu, Stanley K., Cheung, Patrick, Vesprini, Danny, Chu, William, Chung, Hans T., Morton, Gerard, Deabreu, Andrea, Davidson, Melanie, Ravi, Ananth, Musunuru, Hima Bindu, Helou, Joelle, Ho, Ling, Zhang, Liying, Loblaw, Andrew

Volltext

33: Elective Nodal Ultra Hypofractionated Radiation for Prostate Cancer: Safety and Efficacy from Four Prospective Clinical Trials von Glicksman, Rachel, Liu, Stanley K., Cheung, Patrick, Vesprini, Danny, Chu, William, Chung, Hans T., Morton, Gerard, Deabreu, Andrea, Davidson, Melanie, Ravi, Ananth, Musunuru, Hima Bindu, Helou, Joelle, Ho, Ling, Zhang, Liying, Loblaw, Andrew

Volltext

Stereotactic radiotherapy +/- HDR boost for unfavorable-risk prostate cancer: Comparison of efficacy, survival, and late toxicity outcomes von Loblaw, Andrew, Cheung, Patrick, Vesprini, Danny, Liu, Stanley K., Chu, William, Chung, Hans T., Morton, Gerard, Musunuru, Bindu, Deabreu, Andrea, Davidson, Melanie, Ravi, Ananth, Helou, Joelle, Ho, Ling, Zhang, Liying

Volltext

Stereotactic pelvic radiotherapy with HDR boost for dose escalation in intermediate and high-risk prostate cancer (SPARE): Efficacy, survival, and late toxicity outcomes von Loblaw, Andrew, Musunuru, Bindu, Cheung, Patrick, Vesprini, Danny, Liu, Stanley K., Chu, William, Chung, Hans T., Morton, Gerard, Deabreu, Andrea, Davidson, Melanie, Ravi, Ananth, Helou, Joelle, Ho, Ling, Zhang, Liying

Volltext

SABR in high-risk prostate cancer: Outcomes from two prospective clinical trials with and without elective nodal irradiation von Alayed, Yasir, Cheung, Patrick, Vesprini, Danny, Liu, Stanley K., Chu, William, Chung, Hans T., Musunuru, Hima Bindu, Davidson, Melanie, Ravi, Ananth, Ho, Ling, Deabreu, Andrea, D'alimonte, Laura, Bhounr, Zeeba, Zhang, Liying, Commisso, Kristina, Loblaw, Andrew

Volltext

Evaluating the tolerability of a simultaneous focal boost to the gross tumor in prostate SABR: A toxicity and quality-of-life comparison of two prospective trials von Alayed, Yasir, Davidson, Melanie, Chu, William, Liu, Stanley K., Tseng, Chia-Lin, Cheung, Patrick, Vesprini, Danny, Chung, Hans T., Morton, Gerard, Musunuru, Hima Bindu, Ravi, Ananth, Korol, Renee, Deabreu, Andrea, Commisso, Kristina, Bhounr, Zeeba, D'alimonte, Laura, Mittmann, Nicole, Dragomir, Alice, Zhang, Liying, Loblaw, Andrew

Volltext

A comparative study of quality of life in patients with localized prostate cancer treated at a single institution: Stereotactic ablative radiotherapy or external beam + high dose r... von Helou, Joelle, Morton, Gerard, Zhang, Liying, Deabreu, Andrea, D’Alimonte, Laura, Elias, Evelyn, Musunuru, Hima Bindu, Mamedov, Alexandre, Ravi, Ananth, Chung, Hans, Cheung, Patrick, Loblaw, Andrew

Volltext

Low dose rate brachytherapy vs standard external beam radiotherapy vs stereotactic body radiotherapy for low risk prostate cancer: A cost-utility analysis von Helou, Joelle Antoine, Torres, Sofia, Musunuru, Hima Bindu, Cheung, Patrick, Vesprini, Danny, Chung, Hans T., D'Alimonte, Laura, Ravi, Ananth, Krahn, Murray, Morton, Gerard, Loblaw, Andrew

Volltext